Michael J. Farrell, Chairman and CEO at RESMED INC (RMD), sold 4,991 shares at $273.78 ($1.4M) on 2026-02-09, disclosed to the SEC on 2026-02-10.
Scheduled sale ($1.4M) by Chairman and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RMD | SELL | 2026-07-09 | $1.1M | — | Filing → |
| RMD | SELL | 2026-06-09 | $968K | — | Filing → |
| RMD | SELL | 2026-05-11 | $1.0M | — | Filing → |